Bioxcel Therapeutics Logo

Innovative Medicine Backed by the Power of AI

BioXcel Therapeutics, Inc. is a
biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches.

Innovative Medicine
Backed by the
Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Innovative Medicine
Backed by the Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Our Approach to Drug Development

AI-based Drug Development

Our neuroscience and immuno-oncology franchises utilize our AI
approach to drug identification and development

Neuroscience

BXCL501-Neuroscience-image

Immuno-Oncology

BXCL701-Immuno-Oncology-image

Latest News

Dec 01, 2022
BioXcel Therapeutics to Present at Bank of America 2022 Biotech SMID Cap ConferenceVIEW RELEASE
Nov 30, 2022
BioXcel Therapeutics Announces First Patients Dosed in SERENITY III Phase 3 Trial for Acute Treatment of Agitation in Adults with Bipolar I or II Disorder or SchizophreniaVIEW RELEASE
Nov 14, 2022
BioXcel Therapeutics to Present at Two Upcoming Investor ConferencesVIEW RELEASE

Stock Information

BioXcel Therapeutics, Inc.

Dec 07, 2022 04:00 PM

MARKET/SYMBOL

Nasdaq:

BTAI

PRICE

18.47

CHANGE

0.1 (0.54%)